濮阳东方看妇科口碑好收费低濮阳东方妇科技术可靠,濮阳东方医院男科治早泄技术很专业,濮阳市东方医院价格公开,濮阳东方男科口碑如何,濮阳东方男科医院专家怎么样,濮阳东方妇科医院做人流费用价格,濮阳东方医院妇科很不错

WASHINGTON, July 18 (Xinhua) -- The U.S. National Aeronautics and Space Administration (NASA) on Monday commemorated the 90th birthday of astronaut John Glenn, the first U.S. astronaut to orbit the Earth and also the oldest person to fly to space when he launched on the space shuttle in 1998."John Glenn is a legend, and NASA sends him our best wishes on this major personal milestone," NASA Administrator Charles Bolden said in a statement. "John's legacy and contributions to the continued progress of human spaceflight are immense. His example is one we continue to emulate as we push toward farther destinations in the solar system."After a distinguished flying career with the Marines in World War II and Korea, Glenn joined NASA in 1959 as one of the country' s first astronauts in Project Mercury. On Feb. 20, 1962, Glenn piloted the Mercury-Atlas 6 "Friendship 7" spacecraft on the first U.S. manned orbital mission. He launched from NASA's Kennedy Space Center in Florida to successfully complete three orbits of the Earth.Glenn flew to space again on the STS-95 mission in 1998 aboard the space shuttle Discovery. As a mission specialist, Glenn supported deployment of a variety of research payloads and participated in investigations about spaceflight and the aging process.

WELLINGTON, June 7 (Xinhua) -- Scientists in New Zealand have developed a new drug to fight previously untreatable hypoxic cancer tumors, which form in areas of the body starved of oxygen.The researchers at the Auckland University have entered an agreement for the clinical development of CEN-209, which was developed over 10 years of research, said a statement from the university Tuesday.CEN-209 was designed to enhance the effectiveness of radiotherapy and chemotherapy in solid hypoxic tumors, which were resistant to standard cancer therapies, said the statement. In lung cancer patients for example, about half of tumors had hypoxic regions.The new drug worked by damaging the DNA of hypoxic cancer cells, while leaving normal, healthy tissues alone.CEN-209 was designed and created by researchers at the university's Auckland Cancer Society Research Centre (ACSRC), using computer models of drug transport within tumors to accurately predict the anti-tumor activity of the drugs."Our computer models of drug transport developed in-house allowed the synthetic chemists to test their design theories and considerably shortened the discovery process," said Associate Professor Michael Hay, who led the ACSRC research chemists."CEN-209 improves markedly on previous agents in this class in terms of its ability to penetrate tumors, and this is reflected by its improved activity in the laboratory, when combined with long or short courses of radiotherapy," said researcher Professor Bill Wilson.Under the agreement between the university's Auckland UniServices Ltd. and California-based Centella Therapeutics, Inc., a subsidiary of Varian Medical Systems, Inc., Centella will have exclusive rights to CEN-209, which it will develop and trial with Cancer Research UK.The work on CEN-209 is the culmination of a program initiated with funding from the U.S. National Cancer Institute, and more recently from the Maurice Wilkins Centre for Biodiscovery. Ongoing preclinical research on CEN-209 and a backup compound was funded by grants from the Auckland Medical Research Foundation, Genesis Oncology Trust and Health Research Council of New Zealand, said the statement.

BEIJING, Sept. 4 (Xinhua) -- Officials and delegations from China and African countries have gathered at a seminar being held in Beijing to discuss rural development and economic growth.The seven-day seminar kicked off on Sunday, attracting representatives from China and 11 African countries to exchange views and experiences related to the seminar's theme of "agriculture and rural development."Justin Lin Yifu, chief economist and senior vice president of the World Bank, said at the seminar's opening ceremony that African countries should take cues from China's experience in creating a series of policies to bolster agricultural and rural development, as these policies have also facilitated the country's economic growth.Hu Jinglin, assistant to China's Minister of Finance, said improved agricultural cooperation between China and Africa will help enhance global grain security.China has worked on 142 cooperative agricultural projects with 14 African countries to date. In addition, it has sent 104 agricultural experts to 33 African countries to train more than 4,200 local agricultural technicians.

SAN FRANCISCO, July 12 (Xinhua) -- U.S. videogame giant Electronic Arts Inc. (EA) on Tuesday said it has agreed to buy PopCap Games, a leading provider of casual games for digital platforms, in a deal to accelerate its digital transformation.EA said it will pay about 650 million U.S. dollars in cash and 100 million dollars in shares of EA common stock to acquire privately-held PopCap, the maker of blockbuster games including " Plants vs. Zombies," "Bejeweled" and "Zuma".In addition, PopCap's owners are entitled to receive as much as 550 million dollars in earn-outs if certain earnings targets are met through December 2013, according to EA, which is headquartered in Redwood City in the U.S. state of California.Logos of PopCap Games and Electronic Arts Inc."EA and PopCap are a compelling combination," John Riccitiello, EA's chief executive officer, said in a statement."PopCap's great studio talent and powerful IP add to EA's momentum and accelerate our drive towards a 1-billion-dollar digital business," he noted.PopCap is one of the largest providers of casual videogames for mobile phones, tablets, PCs and social network sites, with more than 150 million games installed and played worldwide on platforms such as Facebook, RenRen, Google, iPhone, iPad and Android.EA said the purchase of PopCap is expected to close in August this year, subject to customary closing conditions including regulatory approvals.

WASHINGTON, July 18 (Xinhua) -- Exposure to secondhand smoke ( SHS) is associated with increased risk of hearing loss among adolescents, according to a report in the July issue of Archives of Otolaryngology -- Head and Neck Surgery.Among U.S. children, approximately 60 percent are exposed to SHS, according to background information in the article. Studies have associated exposure to secondhand smoke prenatally or during childhood with various health conditions, from low birth weight and respiratory infections to behavioral problems and otitis media. Children exposed to SHS are more likely to develop recurrent otitis media, the authors note. "Secondhand smoke may also have the potential to have an impact on auditory development, leading to sensorineural hearing loss (SNHL)," they add.Anil Lalwani and colleagues from New York University Langone Medical Center examined the risk factors for SNHL, including SHS, among adolescents, stratified by demographic groups. They included 1,533 individuals from 12 years to 19 years of age who participated in the National Health and Nutrition Examination Survey from 2005 to 2006.Participants were interviewed about their health status and family medical history, exposure to SHS, and self-recognition of hearing impairment. In addition, they underwent a physical examination, including blood testing for cotinine (a by-product of nicotine exposure), and hearing tests.Compared with teens who had no SHS exposure, those who were exposed to secondhand smoke exhibited higher rates of low- and high-frequency hearing loss. The rate of hearing loss appeared to be cumulative, increasing with the level of cotinine detected by blood tests. The results also demonstrated that more than 80 percent of participants with hearing loss did not realize they had impairment.As hearing loss early in life can cause problems with development and functioning, the authors suggest that these results have "significant implications for public health in the United States."They note that most adolescents do not receive screening for hearing loss in the absence of risk factors.If further studies replicate these results, they state, SHS could be considered one such risk factor.